{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:20:58Z","timestamp":1648826458050},"reference-count":31,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.rce.2013.12.011","type":"journal-article","created":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T02:15:24Z","timestamp":1390616124000},"page":"202-208","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Como prevenir y tratar las hipoglucemias farmacol\u00f3gicas"],"prefix":"10.1016","volume":"214","author":[{"given":"R.","family":"Reyes Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mezquita Raya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2013.12.011_bib0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2013.12.011_bib0010","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2013.12.011_bib0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jdiacomp.2005.08.010","article-title":"Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73","volume":"20","author":"Wright","year":"2006","journal-title":"J Diabetes Complic"},{"key":"10.1016\/j.rce.2013.12.011_bib0020","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1210\/jc.2012-4127","article-title":"Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and the Endocrine Society","volume":"98","author":"Seaquist","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rce.2013.12.011_bib0025","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00125-007-0599-y","article-title":"Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration","volume":"50","author":"Heller","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.rce.2013.12.011_bib0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-5491.2005.01501.x","article-title":"Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: A population-based study","volume":"22","author":"Donnelly","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.rce.2013.12.011_bib0035","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2337\/diacare.26.4.1176","article-title":"Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A population-based study of health service resource use","volume":"26","author":"Leese","year":"2003","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.rce.2013.12.011_bib0040","first-page":"A101","article-title":"Incidence and frequency of patient-reported hypoglycemic events in Spain","volume":"62","author":"Orozco Beltran","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.rce.2013.12.011_bib0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/erp.10.73","article-title":"Economic impact of hypoglycemia on healthcare in Spain","volume":"10","author":"Brito-Sanfiel","year":"2010","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.rce.2013.12.011_bib0050","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.rce.2013.02.015","article-title":"Hospitalizations due to severe hypoglycemia in patients with diabetes mellitus in Spain","volume":"213","author":"Lindner","year":"2013","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2013.12.011_bib0055","series-title":"Base de Datos de Costes Sanitarios 1997-2004 [CDROM]","author":"Gisbert","year":"2004"},{"key":"10.1016\/j.rce.2013.12.011_bib0060","doi-asserted-by":"crossref","first-page":"517.e1","DOI":"10.1016\/j.endonu.2013.04.005","article-title":"Documento de posicionamiento: evaluaci\u00f3n y manejo de la hipoglucemia en el paciente con Diabetes Mellitus. Grupo de Trabajo de Diabetes Mellitus de la Sociedad Espa\u00f1ola de Endocrinolog\u00eda y Nutrici\u00f3n (SEEN)","volume":"60","author":"Mezquita-Raya","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.rce.2013.12.011_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.avdiab.2012.01.002","article-title":"Recomendaciones 2012 de la Sociedad Espa\u00f1ola de Diabetes sobre la utilizaci\u00f3n de tiras reactivas para la medici\u00f3n de la glucemia capilar en personas con diabetes","volume":"28","author":"Men\u00e9ndez Torre","year":"2012","journal-title":"Av Diabetol"},{"issue":"1 Suppl A","key":"10.1016\/j.rce.2013.12.011_bib0070","first-page":"S1","article-title":"AHRQ's comparative effectiveness research on oral medications for type 2 diabetes: A summary of the key findings","volume":"18","author":"Bennett","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.rce.2013.12.011_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006423.pub2","article-title":"Glucagon-like peptide analogues for type 2 diabetes mellitus","volume":"10","author":"Shyangdan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rce.2013.12.011_bib0080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1464-5491.2009.02666.x","article-title":"Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)","volume":"26","author":"Marre","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.rce.2013.12.011_bib0085","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc08-2124","article-title":"Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD)","volume":"32","author":"Zinman","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2013.12.011_bib0090","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s00125-009-1472-y","article-title":"Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial","volume":"52","author":"Russell-Jones","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.rce.2013.12.011_bib0095","doi-asserted-by":"crossref","DOI":"10.1111\/j.1463-1326.2012.01639.x","article-title":"Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonist in patients with type 2 diabetes","author":"Ridge","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rce.2013.12.011_bib0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(12)61267-7","article-title":"Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): A randomised, open-label study","volume":"381","author":"Buse","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rce.2013.12.011_bib0105","unstructured":"CG87 Type 2 diabetes - newer agents (a partial update of CG66): short guideline [consultado 23 Nov 2013]. Disponible en: http:\/\/www.nice.org.uk\/guidance\/index.jsp?action=download&o=44318"},{"key":"10.1016\/j.rce.2013.12.011_bib0110","unstructured":"AACE Comprehensive Diabetes Management Algorithm, 2013 [consultado 4 Oct 2013]. Disponible en: http:\/\/www.aace.com\/publications\/algorithm"},{"key":"10.1016\/j.rce.2013.12.011_bib0115","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/dom.12116","article-title":"Cardiovascular safety of sulfonylureas: A meta-analysis of randomized clinical trials","volume":"15","author":"Monami","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rce.2013.12.011_bib0120","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2337\/dc12-2713","article-title":"A Critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?","volume":"36","author":"Butler","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2013.12.011_bib0125","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2337\/dc12-2504","article-title":"A Critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risks","volume":"36","author":"Nauck","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2013.12.011_bib0130","unstructured":"http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2013\/07\/news_detail_001856.jsp&mid=WC0b01ac058004d5c1 [consultado 23 Nov 2013]."},{"key":"10.1016\/j.rce.2013.12.011_bib0135","unstructured":"http:\/\/easd.org\/index.php?option=com_content&view=article&id=172 [consultado 23 Nov 2013]."},{"key":"10.1016\/j.rce.2013.12.011_bib0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1477-7525-11-90","article-title":"Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: A time trade-off survey in five countries","volume":"11","author":"Evans","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.rce.2013.12.011_bib0145","doi-asserted-by":"crossref","first-page":"e1000154","DOI":"10.1371\/journal.pmed.1000154","article-title":"The risk of fractures associated with thiazolidinediones: A self-controlled case-series study","volume":"6","author":"Douglas","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.rce.2013.12.011_bib0150","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1463-1326.2012.01606.x","article-title":"Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: A network meta-analysis","volume":"14","author":"Liu","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rce.2013.12.011_bib0155","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMcp1013127","article-title":"Clinical practice. Glycemic management of type 2 diabetes mellitus","volume":"366","author":"Ismail-Beigi","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256513003998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256513003998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T23:22:55Z","timestamp":1538868175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256513003998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0014256513003998"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2013.12.011","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Como prevenir y tratar las hipoglucemias farmacol\u00f3gicas","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2013.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}